Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).
Cardiac damage framework may identify patients who could benefit from earlier TAVR
- Post author:
- Post published:October 29, 2024
- Post category:uncategorized